140.08 -3.59 (-2.50%)
After hours: 4:29PM EST
|Bid||141.11 x 800|
|Ask||147.93 x 900|
|Day's Range||136.08 - 143.67|
|52 Week Range||119.34 - 156.50|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-4.97%|
|Beta (5Y Monthly)||1.55|
|Expense Ratio (net)||0.57%|
Due to the coronavirus outbreak, a slew of companies are making negative earnings revisions and the carnage isn't limited to withdrawn guidance by some big name technology companies. Some exchange traded funds have large concentrations of components that are making downward revisions. For example, the Amplify Advanced Battery Metals and Materials ETF (NYSE: BATT) downbeat earnings revision tally is close to 48%, according to the ETF Research Center.
VAREX IMAGING (VREX) delivered earnings and revenue surprises of -25.00% and 4.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: ...
Biotechnology stocks and sector-related exchange traded funds stood out on Tuesday after a U.S. District Court overruled President Donald Trump’s wishes to require drugmakers list prices on television ...
The U.S. economy has stepped into the 11th year of the expansion, exhibiting the longest expansion in history. These winning ETFs and stocks will rally further.
We have presented a bunch of top-performing ETFs of the 10-year bull market that will continue to outperform in the coming months given that these have a Zacks ETF Rank 1 (Strong Buy) or 2 (Buy).
Though volatility may persist this year, Churchill Management Group says moneymaking opportunities may exist even for cautious stock market investors.